Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Mallinckrodt
Federal Trade Commission
McKinsey
Johnson and Johnson
Boehringer Ingelheim
Merck
Baxter
Citi

Generated: July 19, 2018

DrugPatentWatch Database Preview

Oxprenolol hydrochloride - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for oxprenolol hydrochloride and what is the scope of oxprenolol hydrochloride patent protection?

Oxprenolol hydrochloride
is the generic ingredient in one branded drug marketed by Novartis and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for oxprenolol hydrochloride.
Summary for oxprenolol hydrochloride
US Patents:0
Tradenames:1
Applicants:1
NDAs:1
Drug Master File Entries: 1
Bulk Api Vendors: 47
Patent Applications: 603
DailyMed Link:oxprenolol hydrochloride at DailyMed
Synonyms for oxprenolol hydrochloride
(+-)-BA 39089
(1)-(3-(2-(Allyloxy)phenoxy)-2-hydroxypropyl)isopropylammonium chloride
1-(2-(Allyloxy)phenoxy)-3-(isopropylamino)propan-2-ol hydrochloride
1-(2-allyloxyphenoxy)-3-(isopropylamino)propan-2-ol hydrochloride
1-(o-Allyloxyphenoxy)-3-isopropylamino-2-propanol hydrochloride
1-(propan-2-ylamino)-3-(2-prop-2-enoxyphenoxy)propan-2-ol hydrochloride
1-(propan-2-ylamino)-3-(2-prop-2-enoxyphenoxy)propan-2-ol;hydrochloride
1-[(1-Methylethyl)amino]-3-[2-(2-propenyloxy)phenoxy]-2-propanol hydrochloride
1-[(1-methylethyl)amino]-3-{[2-(prop-2-en-1-yloxy)phenyl]oxy}propan-2-ol hydrochloride
1-[2-(allyloxy)phenoxy]-3-(isopropylamino)propan-2-ol hydrochloride
1-[2-(Allyloxy)phenoxy]-3-[isopropylamino]-2-propanol
2-(o-Allyloxyphenoxy)-2-hydroxy-N-isopropyl-1-propylamine hydrochloride
2-Propanol, 1-((1-methylethyl)amino)-3-(2-(2-propenyloxy)phenoxy)-, hydrochloride
2-Propanol, 1-((1-methylethyl)amino)-3-(2-(2-propenyloxy)phenoxy)-, hydrochloride, (+-)-
2-Propanol, 1-(o-(allyloxy)phenoxy)-3-(isopropylamino)-, hydrochloride, (+-)-
2-Propanol, 1-(o-allyloxyphenoxy)-3-isopropylamino-, hydrochloride
2-Propanol, 1-[(1-methylethyl)amino]- 3-[2-(2-propenyloxy)phenoxy]-, hydrochloride
22972-97-0
3-[(methylethyl)amino]-1-(2-prop-2-enyloxyphenoxy)propan-2-ol, chloride
6452-71-7 (Parent)
6452-73-9
7348AE
AC1L2FOA
AC1Q3DNG
AK129836
AKOS015994696
AN-19335
API0008993
ARONIS24499
AX8008165
Ba 39089
Ba-39089
BBC/665
C-18840
C-39089-Ba
CAS-6452-73-9
CCG-221057
CCRIS 1097
CHEMBL1200745
Ciba 39089Ba
CTK8E6918
D01806
dl-1-(2-Allylphenoxy)-3-isopropylaminopropan-2-ol hydrochloride
dl-Alprenolol hydrochloride
Drospfta;ome
DSSTox_CID_1093
DSSTox_GSID_21093
DSSTox_RID_75936
DTXSID5021093
EINECS 229-260-5
EINECS 245-358-0
Evinrozit
Flecor
FT-0630349
HMS1571C16
KB-212502
KS-1152
laracor(hydrochloride)
LS-121645
LS-7638
MCULE-5603406124
MFCD00058008
MLS002154132
MolPort-001-770-529
NCGC00016675-01
NCGC00179342-03
Okuspurecol (TN)
OR207695
Oxiprenolol hydrochloride
Oxprenolol HCl
Oxprenolol hydrochloride (JP17/USP)
Oxprenolol hydrochloride [USAN:JAN]
Oxprenolol Hydrochloride 1.0 mg/ml in Methanol (as free base)
Oxprenolol.HCl
OXPRENOLOLHYDROCHLORIDE
Ranidrox
Rixiprol
SBB058171
SCHEMBL123517
Secondafil
Slow-Trasicor
SMR001233439
SR-01000841263
SR-01000841263-2
ST51015083
Tox21_110556
Tox21_110556_1
TR-031398
Vrachor
ZX-AS004866

US Patents and Regulatory Information for oxprenolol hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis TRASICOR oxprenolol hydrochloride CAPSULE;ORAL 018166-004 Dec 28, 1983 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Novartis TRASICOR oxprenolol hydrochloride CAPSULE;ORAL 018166-002 Dec 28, 1983 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Novartis TRASICOR oxprenolol hydrochloride CAPSULE;ORAL 018166-003 Dec 28, 1983 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Novartis TRASICOR oxprenolol hydrochloride CAPSULE;ORAL 018166-001 Dec 28, 1983 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for oxprenolol hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis TRASICOR oxprenolol hydrochloride CAPSULE;ORAL 018166-002 Dec 28, 1983 ➤ Sign Up ➤ Sign Up
Novartis TRASICOR oxprenolol hydrochloride CAPSULE;ORAL 018166-004 Dec 28, 1983 ➤ Sign Up ➤ Sign Up
Novartis TRASICOR oxprenolol hydrochloride CAPSULE;ORAL 018166-003 Dec 28, 1983 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Merck
Citi
Healthtrust
Fuji
McKesson
US Army
Fish and Richardson
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.